{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T04:01:56Z","timestamp":1720238516151},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Agency for Healthcare Research and QualityAgency for Healthcare Research and Quality (AHRQ)","award":["HS022289-01"],"award-info":[{"award-number":["HS022289-01"]}]},{"name":"Agency for Healthcare Research and QualityAgency for Healthcare Research and Quality (AHRQ)","award":["HS022289-01"],"award-info":[{"award-number":["HS022289-01"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ijcard.2016.10.116","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T15:30:26Z","timestamp":1478100626000},"page":"490-496","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Long-term comparative effectiveness of paclitaxel-eluting and everolimus-eluting stents in New York"],"prefix":"10.1016","volume":"227","author":[{"given":"Feng","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward L.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijcard.2016.10.116_bb0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ijcard.2016.10.116_bb0010","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa062598","article-title":"Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention","volume":"355","author":"Laarman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2016.10.116_bb0015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","volume":"119","author":"Stone","year":"2009","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ijcard.2016.10.116_bb0020","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2016.10.116_bb0025","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jcin.2010.09.014","volume":"3","author":"Kereiakes","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"issue":"12","key":"10.1016\/j.ijcard.2016.10.116_bb0030","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jcin.2010.07.017","volume":"3","author":"Caixeta","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"issue":"12","key":"10.1016\/j.ijcard.2016.10.116_bb0035","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4244\/EIJV7I12A217","article-title":"Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial","volume":"7","author":"Kedhi","year":"2012","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.ijcard.2016.10.116_bb0040","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"Smits","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"issue":"9","key":"10.1016\/j.ijcard.2016.10.116_bb0045","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","volume":"6","author":"Dangas","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"issue":"12","key":"10.1016\/j.ijcard.2016.10.116_bb0050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jcin.2013.07.009","volume":"6","author":"Gada","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"issue":"10","key":"10.1016\/j.ijcard.2016.10.116_bb0055","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jcin.2013.05.016","article-title":"A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease)","volume":"6","author":"Ribichini","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"issue":"18","key":"10.1016\/j.ijcard.2016.10.116_bb0060","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMoa1510188","article-title":"Paclitaxel-eluting versus everolimus-eluting coronary stents in diabetes","volume":"373","author":"Kaul","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2016.10.116_bb0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.286.6.708","article-title":"Representation of elderly persons and women in published randomized trials of acute coronary syndromes","volume":"286","author":"Lee","year":"2001","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ijcard.2016.10.116_bb0070","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","article-title":"Representation of the elderly, women, and minorities in heart failure clinical trials","volume":"162","author":"Heiat","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.116_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-8703(03)00189-3","article-title":"Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure","volume":"146","author":"Masoudi","year":"2003","journal-title":"Am. Heart J."},{"issue":"25","key":"10.1016\/j.ijcard.2016.10.116_bb0080","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jacc.2011.12.051","article-title":"The New York State cardiac registries: history, contributions, limitations, and lessons for future efforts to assess and publicly report healthcare outcomes","volume":"59","author":"Hannan","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.ijcard.2016.10.116_bb0085","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat. Med."},{"issue":"17","key":"10.1016\/j.ijcard.2016.10.116_bb0090","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.105.594952","article-title":"Propensity scores in cardiovascular research","volume":"115","author":"D'Agostino","year":"2007","journal-title":"Circulation"},{"issue":"9710","key":"10.1016\/j.ijcard.2016.10.116_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijcard.2016.10.116_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.amjcard.2015.04.010","article-title":"Comparison of outcomes after percutaneous coronary intervention for chronic total occlusion using everolimus- versus sirolimus- versus paclitaxel-eluting stents (from the Korean National Registry of Chronic Total Occlusion Intervention)","volume":"116","author":"Lee","year":"2015","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316333344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316333344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T09:26:30Z","timestamp":1556357190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316333344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":20,"alternative-id":["S0167527316333344"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.116","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term comparative effectiveness of paclitaxel-eluting and everolimus-eluting stents in New York","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}